For the March quarter, the company’s total revenue from operations declined by 25% from the previous quarter to ₹390 crore.
The company reported a net loss of ₹67 crore this time, compared to a net profit of ₹121 crore in the previous quarter. The loss was led by an 81% increase in the total expenses, mostly due to a net loss on fair value changes.
The company continued to lose market share with market-to-market losses dragging it to a net loss, compared to a profit in the previous quarter.
Group AUM at the end of the March quarter stood ₹23.42 lakh crore from ₹23.14 lakh crore last quarter.
The company’s board also recommended a final dividend of ₹40 per equity share for FY26, subject to approval from shareholders at the upcoming annual general meeting.
Prior to this, it had issued a final dividend of ₹26 and special dividend of ₹22 in July 2025, another final and special dividend of ₹24 and ₹23, respectively, in July 2024 and a final dividend of ₹22 in July 2023.
Shares of UTI AMC declined 9.7% to hit an intraday low of ₹935.25 apiece. The stock has declined 16.2% this year, so far.
Also Read: Union Bank of India shares extend losses after Q4 results; Check revised analyst price targets
